Pharma News

Who’s saying what? Virtual Care mentions in company filings of pharmaceutical industry decreased by 38% in Q1 2023

The global pharmaceutical industry experienced a 38% drop in company filings mentions of virtual care in Q1 2023 compared with the previous quarter, with the highest share accounted for by ICON with 25% year-on-year decrease, according to GlobalData’s analysis of over 88 pharmaceutical company filings. GlobalData’s Telehealth Market Size by Segments, Share, Trends, and Forecast, 2022-2030 report provides key insights into business strategies, trends driving the telehealth market and granular data on market segments forecast up to 2030. Buy the report here.

Notably, virtual care was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions, ahead of customer loyalty and cloud, according to GlobalData.

!function(){“use strict”;window.addEventListener(“message”,(function(a){if(void 0!==a.data[“datawrapper-height”]){var e=document.querySelectorAll(“iframe”);for(var t in a.data[“datawrapper-height”])for(var r=0;r<e.length;r++)if(e[r].contentWindow===a.source){var i=a.data["datawrapper-height"][t]+"px";e[r].style.height=i}}}))}();

Of the top leading companies in the pharmaceutical industry, ICON had the greatest increase in references for virtual care in Q1 2023, compared with the previous quarter. GlobalData identified 9 virtual care-related sentences in the company’s filings – 0.3% of all sentences – and an increase of 100% in Q1 2023 compared with Q1 2022. Neurocrine Biosciences’s mentions of virtual care rose by 100% to 3 and UCB’s by 100% to 2 and F. Hoffmann-La Roche’s by 100% to 1 and Pfizer’s by 100% to 1.

!function(){“use strict”;window.addEventListener(“message”,(function(a){if(void 0!==a.data[“datawrapper-height”]){var e=document.querySelectorAll(“iframe”);for(var t in a.data[“datawrapper-height”])for(var r=0;r<e.length;r++)if(e[r].contentWindow===a.source){var i=a.data["datawrapper-height"][t]+"px";e[r].style.height=i}}}))}();

GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for virtual care in Q1 2023 was 60.

!function(){“use strict”;window.addEventListener(“message”,(function(a){if(void 0!==a.data[“datawrapper-height”]){var e=document.querySelectorAll(“iframe”);for(var t in a.data[“datawrapper-height”])for(var r=0;r<e.length;r++)if(e[r].contentWindow===a.source){var i=a.data["datawrapper-height"][t]+"px";e[r].style.height=i}}}))}();

For further understanding of GlobalData’s Telehealth Market Size by Segments, Share, Trends, and Forecast, 2022-2030 buy the report here.

Source link
#Whos #Virtual #Care #mentions #company #filings #pharmaceutical #industry #decreased

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *